EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Predictors of Mortality by an Artificial Intelligence Enhanced Electrocardiogram Model for Cardiac Amyloidosis

Jennifer M Amadio iD, Martha Grogan, Eli Muchtar, Francisco Lopez-Jimenez, Zachi I Attia, Omar AbouEzzeddine, Grace Lin, Surendra Dasari, Suraj Kapa, Daniel D Borgeson, Paul A Friedman, Morie A Gertz und 2 weitere

ESC Heart Failure · 2025

DOI: 10.1002/ehf2.15061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Jennifer M Amadio und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Electrocardiography, Artificial Intelligence, Cardiomyopathies, Amyloidosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Predolin Foundation, NCI NIH HHS, JABBS Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

We aim to determine if our previously validated, diagnostic artificial intelligence (AI) electrocardiogram (ECG) model is prognostic for survival among patients with cardiac amyloidosis (CA).

Methods

A total of 2533 patients with CA (1834 with light chain amyloidosis (AL), 530 with wild-type transthyretin amyloid protein (ATTRwt) and 169 with hereditary transthyretin amyloid (ATTRv)] were included. An amyloid AI ECG (A2E) score was calculated for each patient reflecting the likelihood of CA. CA stage was calculated using the European modification of the Mayo 2004 criteria for AL and Mayo stage for transthyretin amyloid (ATTR). Risk of death was modelled using Cox proportional hazards, and Kaplan–Meier was used to estimate survival.

Results

Median age of the cohort was 67 [inter-quartile ratio (IQR) 59, 74], and 71.6% were male. The median overall survival for the cohort was 35.6 months [95% confidence interval (CI) 32.3, 39.5]. For AL, ATTRwt and ATTRv, respectively, median survival was 22.9 (95% CI 19.2, 28.2), 47.2 (95% CI 43.4, 52.3) and 61.4 (95% CI 48.7, 75.9) months. On univariate analysis, an increasing A2E score was associated with more than a two-fold risk of all-cause death. On multivariable analysis, the A2E score retained its importance with a risk ratio of 2.0 (95% CI 1.58, 2.55) in the AL group and 2.7 (95% CI 1.81, 4.24) in the ATTR group.

Conclusions

Among patients with AL and ATTR amyloidosis, the A2E model helps to stratify risk of CA and adds another dimension of prognostication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ElectrocardiographyArtificial IntelligenceCardiomyopathiesAmyloidosisHumansMaleFemaleAgedPrognosisSurvival RateMiddle AgedRetrospective StudiesFollow-Up StudiesImmunoglobulin Light-chain AmyloidosisAmyloid Neuropathies, FamilialRisk Assessment

Stichwörter der Autor:innen

Artificial intelligenceCardiac amyloidosisMortality

Autor:innen und Institutionen

  • Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Jennifer M Amadio

Förderung

  • Predolin Foundation
  • NCI NIH HHS
  • JABBS Foundation
  • National Cancer Institute
  • Henry J. Predolin Foundation for Research in Leukemia

Zitieren

APA

Amadio, J. M., Grogan, M., Muchtar, E., Lopez-Jimenez, F., Attia, Z. I., AbouEzzeddine, O., Lin, G., Dasari, S., Kapa, S., Borgeson, D. D., Friedman, P. A., Gertz, M. A., Murphree, D. H., & Dispenzieri, A. (2025). Predictors of Mortality by an Artificial Intelligence Enhanced Electrocardiogram Model for Cardiac Amyloidosis. ESC Heart Failure. https://doi.org/10.1002/ehf2.15061

Vancouver

Amadio JM, Grogan M, Muchtar E, Lopez-Jimenez F, Attia ZI, AbouEzzeddine O, et al. Predictors of Mortality by an Artificial Intelligence Enhanced Electrocardiogram Model for Cardiac Amyloidosis. ESC Heart Failure. 2025. doi:10.1002/ehf2.15061

BibTeX
@article{Amadio2025,
  author = {Amadio, Jennifer M and Grogan, Martha and Muchtar, Eli and Lopez-Jimenez, Francisco and Attia, Zachi I and AbouEzzeddine, Omar and Lin, Grace and Dasari, Surendra and Kapa, Suraj and Borgeson, Daniel D and Friedman, Paul A and Gertz, Morie A and Murphree, Dennis H and Dispenzieri, Angela},
  title = {Predictors of Mortality by an Artificial Intelligence Enhanced Electrocardiogram Model for Cardiac Amyloidosis},
  journal = {ESC Heart Failure},
  year = {2025},
  doi = {10.1002/ehf2.15061}
}
Kostenlos starten →